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The impact of cryptosporidiosis is not limited to the diarrhoeal
episode alone but has been associated with long term sequelae,
with several studies suggesting that both asymptomatic and symp-
tomatic cryptosporidial infections have a signiﬁcant adverse effect
on nutritional status, cognitive development, increased overall
diarrhoeal burden and mortality in children.
Although there are studies showinghigh cryptosporidial disease
burden in developing countries, resulting in immediate and pro-
longed morbidity, the epidemiology of cryptosporidial infections
in humans is not clearly understood. Moreover, there is a dearth
of longitudinal data on the course of infection in the absence of
overt diarrheal disease. A clear understanding of the natural history
of cryptosporidiosis and correlates of protection are essential in
developing effective, efﬁcient and sustainable disease control and
preventive measures. In intensive active surveillance of a cohort of
children frombirth till threeyearsof age to study thenaturalhistory
of cryptosporidiosis in a semi-urban slum area in southern India,
we have shown early childhood exposure and a high rate of asymp-
tomatic infection. The proportion of re-infected children was high
and clusteringwas observed in children for both infection and diar-
rhoea. Protection against cryptosporidial infection increased with
theorder of infectionbutwasonly69%after four infections.C. homi-
nis was the predominant Cryptosporidium species, and there was
no evidence of species-speciﬁc protection. Clustering of infection
is suggestive of host susceptibility.Multiple re-infections conferred
some degree of protection against subsequent infection.
These studies demonstrate the power of harnessing the syner-
gistic beneﬁts of a birth cohort study design in a community setting
and efﬁcient molecular approaches to detect cryptosporidial
infections, to enhance understanding of a common but under-
recognised pathogen.
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Abstract: Studies of childhood diarrhea in developing countries
have traditionally employed a wide range of diagnostic modalities
including culture, microscopy, and enzyme immunoassay. Molec-
ular diagnostics offer a substantial increase in sensitivity, however
they also increase the background rate of pathogen detection. A
quantitative analytic approach can help identify the subset of clin-
ically signiﬁcant molecular detections. In this symposium talk, we
will present estimates of of pathogen-speciﬁc attributable fractions
of diarrhea from ongoing re-analyses of two multisite studies of
childhooddiarrhea (GEMSandMAL-ED). Compared to prior burden
estimates from these studies, this approach reveals a substantial
increase in the burden of diarrhea due to pathogens for which con-
ventional diagnostics were not sufﬁciently sensitive, in particular
Shigella, ST-ETEC, and adenovirus 40/41. Burden estimates for other
pathogens, including rotavirus and Cryptosporidium, were not sig-
niﬁcantly changed. After rotavirus, Shigellawas associatedwith the
highest burden of moderate-to-severe non-bloody diarrhea, which
suggests that current guidelines limiting the role of antibiotics
to bloody diarrhea in children in these settings need to be re-
evaluated. These ﬁndings also have signiﬁcant implications for the
prioritization of pathogen-speciﬁc interventions aimed at reducing
the burden of diarrheal disease in children in these settings.
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Abstract: The pathogenesis of severe dengue (SD) is thought
to be due to the complex interplay between the virus, host genes
and the host immune response. As vascular leak, which is the hall
mark of SD, occurs following the resolution of the viraemia, it was
thought that an inappropriate immune response to the virus, was
the main cause of SD. However, recent data shows that dengue
NS1 alone activates monocytes through the TLR4 receptor, induc-
ing inﬂammatory cytokine production and that NS1 was involved
in vascular leak in acute dengue. We too have found that dengue
NS1 stimulates IL-10 production from monocytes, which in turn
could lead to suppression of dengue virus speciﬁc T cell responses
and thereby contribute to disease severity. In our studies, which
have investigated the kinetics of changes in inﬂammatory medi-
ators, the degree of viraemia and the onset and extent of vascular
leak, have shown that inﬂammatorymediators are signiﬁcantly ele-
vated in patients with SD, around day 4 to 5 of illness. Levels of
both IL-10 and IL-17 and other cytokines were signiﬁcantly ele-
vated in patients with SDwhen compared tomilder dengue, before
the onset of vascular leak.
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Our previous studies had shown that platelet activating factor
(PAF) was an important mediator of vascular leak. We found that
although the dengue virus (DENV) or dengue immune serum did
not induce PAF production by monocytes, lipopolysaccharide (LPS)
acted synergistically with the DEN, in the production of PAF. Since
LPS levels in serum have been found to be signiﬁcantly elevated
in SD, LPS could further contribute to disease pathogenesis and
vascular leak.
Mast cells are an important source of PAF and have shown to
be important in disease pathogenesis in dengue mice models. We
found thatmediators such as tryptase and secretoryphospholipase,
which are produced exclusively by mast cells, are signiﬁcantly ele-
vated in patients with DHF, during early infection. Therefore, in
summary, the events that lead to severe dengue appear to occur
before the onset of vascular leak and the role of mast cells and viral
proteins in the pathogenesis of SD should be further investigated.
http://dx.doi.org/10.1016/j.ijid.2016.02.127
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Abstract: Dengue is an important human arboviral disease
caused by infection of four antigenically related strains of dengue
virus (DENV 1-4) belonging to the Flaviviridae family. Despite
extensive worldwide efforts, it remains a major public health con-
cern with 55% of the world’s population estimated to be at risk
for dengue. Infection by any of the four dengue serotypes can
cause a wide spectrum of disease manifestations that ranges from
mild, self-limiting febrile dengue fever to severe, life-threatening
disease. The pathophysiological hallmark that determines disease
severity is the degree of plasma leakage, bleeding and single or
mutli-organ involvement. In recent years, there were several clini-
cal trials using re-purposed pharmaceutical agents to treat dengue,
however none has shown signiﬁcant usefulness for its recommen-
dation for routine use. Lacking the anti-viral agents, management
of dengue is largely supportive in nature. Ability to recognise infec-
tion early and early signs of disease progression remain key in
instituting early and appropriate interventions, preventing dis-
ease progression or late presentation of disease where treatment
options are limited and outcomes are poor. Patients with severe
dengue should be admitted to a hospital with access to intensive
care facilities. Judicious intravenous ﬂuid replacement is critical
to balance the 2 stages between plasma leakage and ﬂuid re-
absorption during recovery phase. Dengue is a dynamic disease
particularly so during the critical phase where plasma volume
changes rapidly, close and frequent monitoring of hematocrit is
critical to guide ﬂuid replacement. Concealed bleeding may pose a
clinical challenge and in instance blood transfusionmay be needed.
Denguemortality can be reducedwith systempriming to recognise
the disease and systematic treatment approach.
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Abstract: Leptospirosis is present worldwide and is especially
important in developing countries, where sanitation is precari-
ous. Sporadic cases are linked to contact with urine-contaminated
water. In tropical countries, urban outbreaks can occur after ﬂoods
in rainy season. Mild non-lethal anicteric forms comprise most
cases and can be easily confused with ﬂu, dengue fever, other
mild viral illnesses and P. vivax malaria. About 5 to 10% of cases
develop severe sepsis-like disease or meningitis during outbreaks.
The serious illness form, also known as Weil’s Disease, courses
with jaundice, shock, renal failure, coagulopathy and other organ
dysfunctions, leading to prolonged hospitalization in intensive
care facilities and death, with high healthcare costs. Differential
diagnosis includes bacterial sepsis, hepatitis, yellow fever, Han-
tavirus disease, P. falciparum malaria and other severe febrile
illnesses. Highly sensitive and speciﬁc rapid diagnosis tests are
commercially lacking. Antibodies or antigen detection by enzyme-
linked assays and nucleic acid detection by PCR in blood or
other body ﬂuids are promising. Mechanisms of disease are little
known, but evidence points out to systemic inﬂammatory response
syndrome-like pathophysiology in severe cases. Spirochete cell
wall proteins, lipopolysaccharide, enzymes like phospholipase and
other bacterial toxic products produce tissue damage and activate
inﬂammatory response locally and systemically, through toll-like
receptors on antigen-presenting cells, triggering cytokine secretion
by innate andadaptive immunecells, resulting in inﬂammatoryand
immune responses. Some patients evolve with shock, coagulopa-
thy, organ failure and death. Which regulatory mechanism leads
to severe disease is not exactly known. Lethality varies widely in
severe cases, reaching 50% in some reports, depending of diagno-
sis and treatment institution speed, level of care and other factors.
